SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : BIOTECH & TECHNOLOGY INVESTING *UNDERVALUED*{T/A F/A & V} -- Ignore unavailable to you. Want to Upgrade?


To: BRAVEHEART who wrote (84)2/22/1999 11:35:00 AM
From: BRAVEHEART  Read Replies (1) | Respond to of 423
 
Hi Gang,

It looks like Viragen has a new convertible financing tucked away with it's most recent SEC filing. I personally will avoid investing any more in that company until it can get past it's dilutive needs. It looks like more smoke & mirrors. Please read the SEC document and form your own opinion.

LONE WOLF



To: BRAVEHEART who wrote (84)2/23/1999 8:30:00 AM
From: CPAMarty  Read Replies (1) | Respond to of 423
 
someone bought 780 April $12.5 call contracts on IMCL (78,000 shares) in one transaction yesterday.
Maybe there is some good news coming down the pike.

cboe.pcquote.com

here are some biotech links
verity.fda.gov
netcognizance.com
www-hgc.lbl.gov
biotech.nature.com

recap.com
centerwatch.com
ncbi.nlm.nih.gov.